St. Marien-Krankenhaus

Hospital


Location: Siegen, Germany (DE) DE

ISNI: -

ROR: https://ror.org/00nkf9b38

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective (2022) Piroth MD, Krug D, Feyer P, Baumann R, Combs S, Duma MN, Dunst J, et al. Journal article, Review article Irradiation of the locoregional Lymphatic Drainage Pathways of Breast Cancer: Is the prescribed Dose actually applied? A Planning Study by the DEGRO Breast Cancer Working Group (2022) Duma MN, Piroth M, Fastner G, Baumann R, Combs S, Dunst J, Feyer P, et al. Conference contribution Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome (2022) Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, et al. Journal article Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article A pre-infection laboratory score identifies cancer patients at risk for severe COVID-19: an analysis of the ADHOK coronavirus tumor registry (2021) Roesch R, Suedhoff T, Wendtner CM, Kullmann F, Schaich M, Kubin T, Mueller-Naendrup C, et al. Conference contribution Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia (2021) Eckardt JN, Stasik S, Kramer M, Röllig C, Krämer A, Scholl S, Hochhaus A, et al. Journal article Long-Term Results of the TARGIT-A Trial: More Questions than Answers (2021) Piroth MD, Strnad V, Krug D, Fastner G, Baumann R, Combs SE, Duma MN, et al. Journal article, Review article Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations–a registry based analysis (2021) Middeke JM, Teipel R, Roellig C, Stasik S, Zebisch A, Sill H, Kramer M, et al. Journal article Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs) (2021) Hamm CW, Schneck E, Buerke M, Darius H, Gaede L, Bergmann M, Hoffmeister M, et al. Journal article, Review article
1 2 3 4